Latest filing published 27 Aug 2021 for SinoMab BioScience Ltd. - B, €9.9M.
Filing timeline
BuySaleInsider track record
MA Huiyuan: trading record in brief
MA Huiyuan is a declared insider of SinoMab BioScience Ltd. - B, with filings sourced from HKEX. The record holds 9 filings, for trades running from 12 November 2019 to 24 August 2021.
No open-market purchase appears, only 6 sales worth €57.3M. No amount is published for 2 filings, which the totals therefore leave out. So far in 2021, the count stands at no purchases and 1 sale.
The newest entry dates from 27 August 2021: an open-market sale of €9.9M, in SinoMab BioScience Ltd. - B. Between a trade and the moment it shows up on HKEX, the median delay is 7 days. The shorter that gap, the sooner other investors can see what insiders have done. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Companies and markets linked to MA Huiyuan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 30,187,212 shares@ HK$3.009.6% of flowShareXHKGHKEX:DA20210827E00020
- 89,802,105 shares@ HK$3.0127.6% of flowShareXHKGHKEX:DA20201228E00015
- 89,802,105 shares@ HK$3.0127.9% of flowShareXHKGHKEX:DA20201214E00034
- 179,930,396 sharesShareXHKGHKEX:DA20201208E00170
- 6,841,915 shares@ HK$3.16352.3% of flowShareXHKGHKEX:DA20201119E00316
- 10,062,404 sharesShareXHKGHKEX:DA20200703E00073
- 41,331,640 shares@ HK$3.5016.5% of flowShareXHKGHKEX:DA20200703E00072
- 41,331,640 shares@ HK$3.5016.0% of flowShareXHKGHKEX:DA20200703E00074
- 389,469,200 sharesShareXHKGHKEX:DA20191120E00042
9 of 6 declarations